Business Context and Reporting Period
This Form 8-K was filed by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) on November 5, 2014, reporting an event that occurred on October 31, 2014. The filing concerns a material definitive agreement entered into by Zimmer K.K., a wholly-owned subsidiary of the registrant.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, or liquidity metrics. The only financial figure disclosed relates to a specific debt instrument:
- Debt Instrument: Yen 11.7 billion term loan agreement.
- Original Maturity Date: May 31, 2016.
- New Maturity Date: May 31, 2018.
Material Changes
The primary material change reported is the extension of the maturity date for the Yen 11.7 billion term loan agreement between Zimmer K.K. and Sumitomo Mitsui Banking Corporation. The maturity was extended by two years, from May 31, 2016, to May 31, 2018, via the First Amendment to the Loan Agreement dated May 24, 2012.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies are detailed in the text of this report, other than the standard reference to the full text of the Amendment (Exhibit 10.1) for complete terms.
Investor Verification Checklist
- Verify the full terms of the First Amendment to the Yen 11.7 billion term loan agreement in Exhibit 10.1.
- Confirm whether the extension of the loan maturity impacts the company's overall debt maturity profile or liquidity ratios.
- Check for any changes in interest rates or covenants associated with the amended loan agreement.